Inhibition of autophagy enhances the anticancer activity of bortezomib in B-cell acute lymphoblastic leukemia cells

B-cell acute lymphoblastic leukemia (B-ALL) remains a challenging disease to treat in adults because of the high rates of relapse and refractory. Bortezomib, as a proteasome inhibitor, exerts obvious cytotoxicity against ALL cells and increases the sensitivity of ALL cells to conventional chemothera...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Cancer Res
Главные авторы: Wang, Zhihua, Zhu, Shicong, Zhang, Guangsen, Liu, Sufang
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396044/
https://ncbi.nlm.nih.gov/pubmed/25973303
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы